Cristina Encinas

4PUBLICATIONS
41CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersPharmacogenomicsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 07, 2025
Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain.

Cristina Encinas, Virginia Lozano, Patrick Hlavacek

|Oct 01, 2024
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma.

Marta Lasa, Laura Notarfranchi, Cristina Agullo

|Mar 07, 2023
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

Philippe Moreau, Ajai Chari, Albert Oriol

|Apr 20, 2022
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma.

Cristina Encinas, José-Ángel Hernandez-Rivas, Albert Oriol

Pageof 1

Frequent Collaborators

3 joint publications

Albert Oriol

3 joint publications

Joaquín Martínez-López

2 joint publications

Laura Rosiñol

2 joint publications

Javier de la Rubia Comos